MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 144 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 2.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,617,000 | +37.7% | 412,189 | +81.5% | 0.36% | +41.3% |
| Q1 2016 | $1,900,000 | -49.8% | 227,051 | -48.9% | 0.25% | -49.3% |
| Q3 2015 | $3,783,000 | -53.9% | 444,550 | -33.1% | 0.50% | -56.4% |
| Q2 2015 | $8,214,000 | +28.1% | 664,298 | +23.1% | 1.15% | -2.3% |
| Q1 2015 | $6,411,000 | -6.6% | 539,626 | -11.1% | 1.18% | -14.5% |
| Q4 2014 | $6,862,000 | +84.8% | 607,288 | +43.6% | 1.38% | +62.9% |
| Q3 2014 | $3,714,000 | – | 422,975 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |